Adicon (HKG:9860) saw a decline in attributable profit in the first half of 2025 to 27.3 million yuan from 101.6 million yuan in the year-ago period, a Friday filing with the Hong Kong bourse said.

Earnings per share stood at 0.04 yuan in the interim period, down from 0.14 yuan in the corresponding period of the last year.

The clinical laboratory service provider's revenue fell 13% to 1.27 billion yuan in the half year from 1.47 billion yuan a year prior due to industry headwinds arising from a disproportional price and demand relationship.